A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01372410 · COMPLETED
Trial details
- NCT number
- NCT01372410
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.